These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens. Golovkina T; Agafonova Y; Kazansky D; Chervonsky A J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278 [TBL] [Abstract][Full Text] [Related]
6. [Structures of bacterial superantigen on the molecular basis and their activities to the immune system]. Miyoshi-Akiyama T; Uchiyama T Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):567-74. PubMed ID: 11268662 [No Abstract] [Full Text] [Related]
7. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications. Deacy AM; Gan SK; Derrick JP Front Immunol; 2021; 12():731845. PubMed ID: 34616400 [TBL] [Abstract][Full Text] [Related]
8. A maternally inherited superantigen encoded by a mammary tumour virus. Marrack P; Kushnir E; Kappler J Nature; 1991 Feb; 349(6309):524-6. PubMed ID: 1846947 [TBL] [Abstract][Full Text] [Related]
9. Intercellular transfer of a soluble viral superantigen. Reilly M; Mix D; Reilly AA; Ye XY; Winslow GM J Virol; 2000 Sep; 74(18):8262-7. PubMed ID: 10954523 [TBL] [Abstract][Full Text] [Related]
10. The bacterial superantigen and superantigen-like proteins. Fraser JD; Proft T Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785 [TBL] [Abstract][Full Text] [Related]
11. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation]. Okamoto M; Kimura S; Katagiri M Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947 [TBL] [Abstract][Full Text] [Related]
12. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671 [TBL] [Abstract][Full Text] [Related]
13. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis. Hsu PN; Wolf Bryant P; Sutkowski N; McLellan B; Ploegh HL; Huber BT J Immunol; 2001 Mar; 166(5):3309-14. PubMed ID: 11207286 [TBL] [Abstract][Full Text] [Related]
15. Superantigens and their role in immune-mediated disease. Hauser C; Orbea HA J Invest Dermatol; 1993 Oct; 101(4):503-5. PubMed ID: 7691970 [No Abstract] [Full Text] [Related]
16. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. Labrecque N; Thibodeau J; Mourad W; Sékaly RP J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467 [TBL] [Abstract][Full Text] [Related]
17. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. Braunstein NS; Weber DA; Wang XC; Long EO; Karp D J Exp Med; 1992 May; 175(5):1301-5. PubMed ID: 1569399 [TBL] [Abstract][Full Text] [Related]
18. Superantigens and their potential role in human disease. Kotzin BL; Leung DY; Kappler J; Marrack P Adv Immunol; 1993; 54():99-166. PubMed ID: 8397479 [TBL] [Abstract][Full Text] [Related]
19. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
20. Superantigens - powerful modifiers of the immune system. Fraser J; Arcus V; Kong P; Baker E; Proft T Mol Med Today; 2000 Mar; 6(3):125-32. PubMed ID: 10689316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]